Genomic Cancer Panel And Profiling Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Genomic Cancer Panel And Profiling Market Size Forecast: How Large Could The Market Become By 2030?
The market for genomic cancer panels and profiling has experienced significant expansion in recent years. Valued at $10.28 billion in 2025, it is projected to reach $11.17 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.7%. This historic growth has been fueled by increasing cancer incidence, progress in sequencing technologies, broader oncology diagnostic applications, greater investment in genomic research, and a growing embrace of precision medicine.
Strong expansion is anticipated for the genomic cancer panel and profiling sector over the coming years. By 2030, its value is projected to reach $15.45 billion, progressing at a compound annual growth rate (CAGR) of 8.4%. This forecasted growth is driven by several factors, including the broadening scope of companion diagnostics, a rising uptake of liquid biopsy methods, the incorporation of artificial intelligence into genomic analysis, the growth of oncology screening efforts, and the emergence of more affordable sequencing technologies. Key developments shaping this period are a greater preference for multi-gene cancer panels, the widespread application of next-generation sequencing, the broadening of liquid biopsy use, heightened interest in personalized cancer treatments, and the incorporation of genomic data into clinical decision-making.
Download A Free Sample Report For Comprehensive Market Insights:
Genomic Cancer Panel And Profiling Market Demand Drivers Creating New Revenue Opportunities
Rising rates of cancer diagnoses are expected to fuel the expansion of the genomic cancer panel and profiling market in the coming years. Cancer is defined by the abnormal and uncontrolled proliferation of cells within the body. This increase in cancer cases is linked to an aging global population, as longer life expectancy heightens the likelihood of developing the disease. Genomic cancer panels and profiling support oncology practices by detecting genetic mutations and biomarkers, enabling tailored treatment plans, and enhancing early detection and ongoing monitoring. As an example, in January 2024, the American Cancer Society, a U.S.-based nonprofit organization, reported that around 20 million new cancer cases were documented worldwide in 2022, leading to 9.7 million deaths; primarily due to population growth, the global cancer burden is expected to climb to 35 million cases by 2050. Consequently, the rising number of cancer diagnoses will drive the growth of the genomic cancer panel and profiling market.
Genomic Cancer Panel And Profiling Market Segment Analysis And Revenue Opportunities
The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
Genomic Cancer Panel And Profiling Market Trends Driving Strategic Industry Expansion
Key industry players within the genomic cancer panel and profiling market are increasingly investing in technological innovations, particularly next-generation sequencers, to enhance the precision, efficiency, and breadth of cancer diagnostics, ultimately supporting more tailored therapeutic decisions. These sequencers represent sophisticated DNA analysis tools capable of rapid, high-volume evaluation of genetic material, detecting mutations, variations, and other genomic markers. A notable example occurred in April 2025, when QIAGEN N.V., a biotechnology firm based in the Netherlands, introduced its QIAseq panels specifically for use with next-generation sequencers. These panels allow comprehensive genomic profiling by examining over 700 genes, designed to serve both research and clinical settings with the goal of advancing cancer detection and treatment planning.
Genomic Cancer Panel And Profiling Market Leading Players Shaping Industry Direction
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.
Access The Complete Genomic Cancer Panel And Profiling Market Report:
Genomic Cancer Panel And Profiling Market Regional Analysis And Leading Geography
North America was the largest region in the genomic cancer panel and profiling market in 2025. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
